ClinicalTrials.Veeva

Menu

Effects of Intraoperative GDFT on the Postoperative Brain Edema

Capital Medical University logo

Capital Medical University

Status

Completed

Conditions

Fluid Therapy
Brain Edema
Brain Tumor

Treatments

Other: traditional fluid therapy
Other: GDFT

Study type

Interventional

Funder types

Other

Identifiers

NCT03323580
2017-10-24

Details and patient eligibility

About

Whether a fluid protocol aiming for protecting vital organ perfusion or fluid restriction is favorable to post-craniotomy outcomes such as brain edema remains uncertain. To our knowledge, there has been no extensive and quantitative analysis of brain edema following SVV-based GDFT in neurosurgical patients with malignant supratentorial glioma. So the study aims to observe the effect of the stroke volume variation-based GDFT on the postoperative brain edema and decrease the incidence of postoperative complications in neurosurgical patients with malignant supratentorial gliomas.

Enrollment

480 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Preoperative brain image indicating high-grade glioma (HGG), verified by postoperative histology of the World Health Organization (WHO) as grade III or IV tumors.
  2. Age 18-65 years, and American Society of Anaesthesiologists (ASA) physical status I to III.
  3. Signed informed consent.

Exclusion criteria

  1. Renal insufficiency or the creatinine clearance is < 30 mL/kg.
  2. Heart disease, New York Heart Association Functional Classification (NYHA) class II or higher heart failure, or if their cardiac ejection fraction is < 20%.
  3. Chronic obstructive pulmonary disease.
  4. Extensive peripheral arterial occlusive disease.
  5. Coagulopathy.
  6. Surgery in the prone position.
  7. Recurrent carcinoma or tumor in the brain ventricular.
  8. Body Mass Index <18.5 kg·m-2 or >30.0 kg·m-2.
  9. Awake craniotomy.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

480 participants in 2 patient groups

GDFT group
Experimental group
Description:
The patients will receive fluid therapy under goal directed.
Treatment:
Other: GDFT
Routine group
Sham Comparator group
Description:
The patients will receive routine fluid therapy.
Treatment:
Other: traditional fluid therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems